Bio-pharma and vaccine industries require large investment in time and capital to effectively translate scientific discovery into novel and affordable therapies. With decades of experience, DDE has become a strategic driver in providing scalable and flexible bioprocess solutions of high quality.
Emergence of new diseases is constantly pushing bio-pharma and vaccine industries to innovate novel therapies and drugs. DDE provides sophisticated and smarter ecosystems to help overcome these challenges.